NewGenIvf Group (NASDAQ:NIVF – Get Free Report) and Quipt Home Medical (NASDAQ:QIPT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability.
Valuation & Earnings
This table compares NewGenIvf Group and Quipt Home Medical”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NewGenIvf Group | $5.14 million | 0.23 | $130,000.00 | N/A | N/A |
| Quipt Home Medical | $245.91 million | 0.48 | -$6.76 million | ($0.17) | -16.06 |
NewGenIvf Group has higher earnings, but lower revenue than Quipt Home Medical.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NewGenIvf Group | 0 | 0 | 0 | 0 | 0.00 |
| Quipt Home Medical | 1 | 0 | 3 | 2 | 3.00 |
Quipt Home Medical has a consensus target price of $6.25, indicating a potential upside of 128.94%. Given Quipt Home Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Quipt Home Medical is more favorable than NewGenIvf Group.
Profitability
This table compares NewGenIvf Group and Quipt Home Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NewGenIvf Group | N/A | N/A | N/A |
| Quipt Home Medical | -2.90% | -6.70% | -2.94% |
Risk & Volatility
NewGenIvf Group has a beta of -0.35, meaning that its share price is 135% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500.
Institutional & Insider Ownership
66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by insiders. Comparatively, 13.4% of Quipt Home Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
Quipt Home Medical beats NewGenIvf Group on 7 of the 13 factors compared between the two stocks.
About NewGenIvf Group
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
About Quipt Home Medical
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.
